Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ribonucleic acid binding protein-mediated regulation of luteinizing hormone receptor expression in granulosa cells: relationship to sterol metabolism.

Molecular endocrinology (Baltimore, Md.)·2007
Same author

Psychological stress-induced oxidative stress as a model of sub-healthy condition and the effect of TCM.

Evidence-based complementary and alternative medicine : eCAM·2007
Same author

Overexpression of OsCOIN, a putative cold inducible zinc finger protein, increased tolerance to chilling, salt and drought, and enhanced proline level in rice.

Planta·2007
Same author

Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network.

Bioinformatics (Oxford, England)·2007
Same author

[The value of long-term postoperative follow-up after curative resection of lung cancer and common problems associated with it].

Nihon Geka Gakkai zasshi·2007
Same author

Identification of a type III thioesterase reveals the function of an operon crucial for Mtb virulence.

Chemistry & biology·2007

Related Experiment Video

Updated: Mar 2, 2026

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.7K

Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.

Lei Wang1, Li Li1, Zi-Han Zhou2

  • 1State Key Laboratory of Natural Medicines, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

European Journal of Medicinal Chemistry
|May 9, 2017
PubMed
Summary

Researchers identified novel small molecules targeting the Hsp90-Cdc37 protein-protein interaction (PPI). Compound 10 showed potent antiproliferative activity against cancer cells, representing a new class of Hsp90-Cdc37 PPI inhibitors.

Keywords:
Hsp90-Cdc37Protein-protein interactionVirtual screening

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.5K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.5K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Heat shock protein 90 (Hsp90) is a crucial molecular chaperone involved in cancer progression.
  • Targeting the Hsp90-Cdc37 protein-protein interaction (PPI) offers an alternative strategy for Hsp90 inhibition.
  • Developing small molecules to disrupt this specific PPI is a promising area for cancer therapy.

Purpose of the Study:

  • To identify and characterize novel small molecules that inhibit the Hsp90-Cdc37 PPI.
  • To optimize lead compounds through structure-activity relationship (SAR) analysis.
  • To evaluate the antiproliferative effects of identified compounds against various cancer cell lines.

Main Methods:

  • Structure-based virtual screening was employed to identify initial hit compounds.
  • Synthesis of derivative compounds based on virtual screening results.
  • Biological evaluation including inhibitory concentration (IC50) and binding affinity (KD) measurements.
  • Antiproliferative assays against MCF-7, SKBR3, and A549 cancer cell lines.

Main Results:

  • Virtual screening identified potential inhibitors of the Hsp90-Cdc37 complex.
  • Structural optimization led to the discovery of compound 10.
  • Compound 10 demonstrated a promising inhibitory effect (IC50 = 27 μM) and moderate binding capacity (KD = 40 μM).
  • Compound 10 exhibited significant antiproliferative activity against MCF-7 (IC50 = 26 μM), SKBR3 (IC50 = 15 μM), and A549 (IC50 = 38 μM) cell lines.

Conclusions:

  • Compound 10 is a novel, non-natural small molecule that effectively targets the Hsp90-Cdc37 PPI.
  • The findings provide initial evidence for targeting this specific PPI with small molecules.
  • Compound 10 warrants further investigation as a potential anticancer therapeutic agent.